Skip to main content
Log in

Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention and therapeutics—update 2022

Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Fractional flow reserve and instantaneous wave-free ratio are widely accepted and recommended in Western and Japanese guidelines for appropriate percutaneous coronary intervention. There are, however, many differences in clinical situations between Japan and Western countries. Therefore, the Task Force on coronary physiology of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) has proposed an expert consensus document to summarize current evidence and suggest the practical use of physiological lesion assessment in Japan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS, Group CTR. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.

    Article  CAS  PubMed  Google Scholar 

  2. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, Bhindi R, Lehman SJ, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Harle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Canas Silva P, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017;376:1824–34.

    Article  PubMed  Google Scholar 

  3. Gotberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, Olsson SE, Ohagen P, Olsson H, Omerovic E, Calais F, Lindroos P, Maeng M, Todt T, Venetsanos D, James SK, Karegren A, Nilsson M, Carlsson J, Hauer D, Jensen J, Karlsson AC, Panayi G, Erlinge D, Frobert O, i FRSI. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 2017;376:1813–23.

    Article  PubMed  Google Scholar 

  4. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ, Group ESCSD. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.

    Article  PubMed  Google Scholar 

  5. Nakamura M, Yaku H, Ako J, Arai H, Asai T, Chikamori T, Daida H, Doi K, Fukui T, Ito T, Kadota K, Kobayashi J, Komiya T, Kozuma K, Nakagawa Y, Nakao K, Niinami H, Ohno T, Ozaki Y, Sata M, Takanashi S, Takemura H, Ueno T, Yasuda S, Yokoyama H, Fujita T, Kasai T, Kohsaka S, Kubo T, Manabe S, Matsumoto N, Miyagawa S, Mizuno T, Motomura N, Numata S, Nakajima H, Oda H, Otake H, Otsuka F, Sasaki KI, Shimada K, Shimokawa T, Shinke T, Suzuki T, Takahashi M, Tanaka N, Tsuneyoshi H, Tojo T, Une D, Wakasa S, Yamaguchi K, Akasaka T, Hirayama A, Kimura K, Kimura T, Matsui Y, Miyazaki S, Okamura Y, Ono M, Shiomi H, Tanemoto K, Japanese Circulation Society Joint Working G. JCS/JSCVS 2018 guideline on revascularization of stable coronary artery disease. Circ J. 2022;86:477–588.

    Article  PubMed  Google Scholar 

  6. Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, Manabe S, Matsuo H, Nakamura M, Ohno T, Sawano M, Toda K, Ueda Y, Yokoi H, Gatate Y, Kasai T, Kawase Y, Matsumoto N, Mori H, Nakazato R, Niimi N, Saito Y, Shintani A, Watanabe I, Watanabe Y, Ikari Y, Jinzaki M, Kosuge M, Nakajima K, Kimura T, Group JCSJW. JCS 2022 guideline focused update on diagnosis and treatment in patients with stable coronary artery disease. Circ J. 2022;86:882–915.

    Article  PubMed  Google Scholar 

  7. Hoffman JI. Maximal coronary flow and the concept of coronary vascular reserve. Circulation. 1984;70:153–9.

    Article  CAS  PubMed  Google Scholar 

  8. Klocke FJ. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation. 1987;76:1183–9.

    Article  CAS  PubMed  Google Scholar 

  9. Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, el Gamal MI. Fractional flow reserve a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183–93.

    Article  CAS  PubMed  Google Scholar 

  10. De Bruyne B, Paulus WJ, Pijls NH. Rationale and application of coronary transstenotic pressure gradient measurements. Cathet Cardiovasc Diagn. 1994;33:250–61.

    Article  PubMed  Google Scholar 

  11. Berry C, van’t Veer M, Witt N, Kala P, Bocek O, Pyxaras SA, McClure JD, Fearon WF, Barbato E, Tonino PA, De Bruyne B, Pijls NH, Oldroyd KG. VERIFY (verification of instantaneous wave-free ratio and fractional flow reserve for the assessment of coronary artery stenosis severity in everyday practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013;61:1421–7.

    Article  PubMed  Google Scholar 

  12. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703–8.

    Article  CAS  PubMed  Google Scholar 

  13. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF, Investigators FT. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001.

    Article  PubMed  CAS  Google Scholar 

  14. Kuramitsu S, Matsuo H, Shinozaki T, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Mizuno A, Tsujita K, Masamura K, Yokoi H, Tanaka N, J-CONFRIM Investigators. Two-year outcomes after deferral of revascularization based on fractional flow reserve: the J-CONFIRM registry. Circ Cardiovasc Interv. 2020;13:e008355.

    Article  PubMed  Google Scholar 

  15. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O’Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE, Investigators C. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91.

    Article  PubMed  Google Scholar 

  16. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928–34.

    Article  CAS  PubMed  Google Scholar 

  17. Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G, Investigators P. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia study). JACC Cardiovasc Interv. 2014;7:20–8.

    Article  PubMed  Google Scholar 

  18. Pijls NH, van’t Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van Veer M, Bar F, Hoorntje J, Koolen J, Wijns W, de Bruyne B. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol. 2007;49:2105–11.

    Article  PubMed  Google Scholar 

  19. Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR, van Schaardenburgh P, Bech GJ, De Bruyne B, Pijls NH. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015;36:3182–8.

    Article  PubMed  Google Scholar 

  20. Tanaka N, Nakamura M, Akasaka T, Kadota K, Uemura S, Amano T, Shiode N, Morino Y, Fujii K, Hikichi Y, Investigators C-DR. One-year outcome of fractional flow reserve-based coronary intervention in Japanese daily practice- CVIT-DEFER registry. Circ J. 2017;81:1301–6.

    Article  PubMed  Google Scholar 

  21. Kuramitsu S, Matsuo H, Shinozaki T, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Yokoi H, Tanaka N, J-CONFIRM Investigators. Five-year outcomes after fractional flow reserve-based deferral of revascularization in chronic coronary syndrome: final results from the J-CONFIRM registry. Circ Cardiovasc Interv. 2022;15:e011387. https://doi.org/10.1161/CIRCINTERVENTIONS.121.011387.

    Article  CAS  PubMed  Google Scholar 

  22. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.

    Article  CAS  PubMed  Google Scholar 

  23. Botman CJ, Schonberger J, Koolen S, Penn O, Botman H, Dib N, Eeckhout E, Pijls N. Does stenosis severity of native vessels influence bypass graft patency? a prospective fractional flow reserve-guided study. Ann Thorac Surg. 2007;83:2093–7.

    Article  PubMed  Google Scholar 

  24. Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G, Xaplanteris P, Milkas A, Strisciuglio T, Bartunek J, Vanderheyden M, Wyffels E, Casselman F, Van Praet F, Stockman B, Degrieck I, Barbato E. Six-year follow-up of fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circ Cardiovasc Interv. 2018;11: e006368.

    Article  PubMed  Google Scholar 

  25. Thuesen AL, Riber LP, Veien KT, Christiansen EH, Jensen SE, Modrau I, Andreasen JJ, Junker A, Mortensen PE, Jensen LO. Fractional flow reserve versus angiographically-guided coronary artery bypass grafting. J Am Coll Cardiol. 2018;72:2732–43.

    Article  PubMed  Google Scholar 

  26. Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial. EuroIntervention. 2019;15:e999–1005.

    Article  PubMed  Google Scholar 

  27. Glineur D, Grau JB, Etienne PY, Benedetto U, Fortier JH, Papadatos S, Laruelle C, Pieters D, El Khoury E, Blouard P, Timmermans P, Ruel M, Chong AY, So D, Chan V, Rubens F, Gaudino MF. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. Eur Heart J. 2019;40:2421–8.

    Article  PubMed  Google Scholar 

  28. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354–67.

    Article  CAS  PubMed  Google Scholar 

  29. Pijls NH. Fractional flow reserve to guide coronary revascularization. Circ J. 2013;77:561–9.

    Article  PubMed  Google Scholar 

  30. Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, Fearon WF, Barbato E, Kern MJ, Pijls NH, De Bruyne B. Standardization of fractional flow reserve measurements. J Am Coll Cardiol. 2016;68:742–53.

    Article  PubMed  Google Scholar 

  31. Moriyama N, Yamanaka F, Shishido K, Tobita K, Yokota S, Hayashi T, Koike T, Miyashita H, Yokoyama H, Nishimoto T, Takada T, Ochiai T, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Saito S. The COFFEE trial (comparison of fractional flow reserve measurements through 4 FrEnch versus 6 FrEnch diagnostic catheter). JACC Cardiovasc Interv. 2018;11:414–6.

    Article  PubMed  Google Scholar 

  32. Inoue F, Hashimoto T, Fujimoto S, Uemura S, Kawamoto A, Dohi K. Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine. Heart Vessels. 1998;13:229–36.

    Article  CAS  PubMed  Google Scholar 

  33. Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, Yang HM, Park KW, Nam CW, Doh JH, Kim HS. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J. 2013;34:2055–62.

    Article  CAS  PubMed  Google Scholar 

  34. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation. 1986;73:444–51.

    Article  CAS  PubMed  Google Scholar 

  35. Nakayama M, Tanaka N, Sakoda K, Hokama Y, Hoshino K, Kimura Y, Ogawa M, Yamashita J, Kobori Y, Uchiyama T, Aizawa Y, Yamashina A. Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease. Circ J. 2015;79:530–6.

    Article  PubMed  Google Scholar 

  36. De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR. Intracoronary and intravenous adenosine 5’-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107:1877–83.

    Article  PubMed  CAS  Google Scholar 

  37. Oi M, Toyofuku M, Matsumura Y, Motohashi Y, Takahashi K, Kawase Y, Ko E, Tanaka M, Kitada M, Yuzuki Y, Tamura T, Tanaka N, Kimura T. Utility of nicorandil for the measurement of coronary fractional flow reserve. Cardiovasc Interv Ther. 2014;29:24–30.

    Article  CAS  PubMed  Google Scholar 

  38. Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van’t Veer M, Pijls NH. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816–21.

    Article  PubMed  Google Scholar 

  39. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Tahk SJ. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol. 2005;46:633–7.

    Article  PubMed  Google Scholar 

  40. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Akasaka T, Tanaka N, Kimura T. Prevalence of visual-functional mismatch regarding coronary artery stenosis in the CVIT-DEFER registry. Cardiovasc Interv Ther. 2014;29:300–8.

    Article  PubMed  Google Scholar 

  41. Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E, Heyndrickx GR, Wijns W, De Bruyne B. Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009;120:1505–12.

    Article  PubMed  Google Scholar 

  42. Lee JM, Koo BK, Shin ES, Nam CW, Doh JH, Hu X, Ye F, Chen S, Yang J, Chen J, Tanaka N, Yokoi H, Matsuo H, Takashima H, Shiono Y, Hwang D, Park J, Kim KJ, Akasaka T, Wang J. Clinical outcomes of deferred lesions with angiographically insignificant stenosis but low fractional flow reserve. J Am Heart Assoc. 2017;6:e006071.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Van Belle E, Gil R, Klauss V, Balghith M, Meuwissen M, Clerc J, Witzenbichler B, Cercek M, Vlachojannis M, Lang I, Commeau P, Vincent F, Testa L, Wasek W, Debry N, Kische S, Gabrielli G, Sardella G. Impact of routine invasive physiology at time of angiography in patients with multivessel coronary artery disease on reclassification of revascularization strategy: results from the DEFINE REAL study. JACC Cardiovasc Interv. 2018;11:354–65.

    Article  PubMed  Google Scholar 

  44. Tu S, Westra J, Adjedj J, Ding D, Liang F, Xu B, Holm NR, Reiber JHC, Wijns W. Fractional flow reserve in clinical practice: from wire-based invasive measurement to image-based computation. Eur Heart J. 2020;41:3271–9.

    Article  PubMed  Google Scholar 

  45. Kogame N, Ono M, Kawashima H, Tomaniak M, Hara H, Leipsic J, Andreini D, Collet C, Patel MR, Tu S, Xu B, Bourantas CV, Lerman A, Piek JJ, Davies JE, Escaned J, Wijns W, Onuma Y, Serruys PW. The impact of coronary physiology on contemporary clinical decision making. JACC Cardiovasc Interv. 2020;13:1617–38.

    Article  PubMed  Google Scholar 

  46. Yamanaka F, Shishido K, Ochiai T, Moriyama N, Yamazaki K, Sugitani A, Tani T, Tobita K, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Yamazaki S, Saito S. Instantaneous wave-free ratio for the assessment of intermediate coronary artery stenosis in patients with severe aortic valve stenosis: comparison with myocardial perfusion scintigraphy. JACC Cardiovasc Interv. 2018;11:2032–40.

    Article  PubMed  Google Scholar 

  47. Cuculi F, De Maria GL, Meier P, Dall’Armellina E, de Caterina AR, Channon KM, Prendergast BD, Choudhury RP, Forfar JC, Kharbanda RK, Banning AP. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1894–904.

    Article  PubMed  Google Scholar 

  48. Ntalianis A, Sels JW, Davidavicius G, Tanaka N, Muller O, Trana C, Barbato E, Hamilos M, Mangiacapra F, Heyndrickx GR, Wijns W, Pijls NH, De Bruyne B. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2010;3:1274–81.

    Article  PubMed  Google Scholar 

  49. Lee JM, Kim HK, Lim KS, Park JK, Choi KH, Park J, Hwang D, Rhee TM, Yang JH, Shin ES, Nam CW, Doh JH, Hahn JY, Koo BK, Jeong MH. Influence of local myocardial damage on index of microcirculatory resistance and fractional flow reserve in target and nontarget vascular territories in a porcine microvascular injury model. JACC Cardiovasc Interv. 2018;11:717–24.

    Article  PubMed  Google Scholar 

  50. De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W. Fractional flow reserve in patients with prior myocardial infarction. Circulation. 2001;104:157–62.

    Article  PubMed  Google Scholar 

  51. Smits PC, Abdel-Wahab M, Neumann FJ, Boxma-de Klerk BM, Lunde K, Schotborgh CE, Piroth Z, Horak D, Wlodarczak A, Ong PJ, Hambrecht R, Angeras O, Richardt G, Omerovic E, Compare-Acute I. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234–44.

    Article  PubMed  Google Scholar 

  52. Engstrom T, Kelbaek H, Helqvist S, Hofsten DE, Klovgaard L, Holmvang L, Jorgensen E, Pedersen F, Saunamaki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aaroe J, Jensen SE, Raungaard B, Kober L, Investigators D-P. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–71.

    Article  PubMed  Google Scholar 

  53. Puymirat E, Cayla G, Simon T, Steg PG, Montalescot G, Durand-Zaleski I, le Bras A, Gallet R, Khalife K, Morelle JF, Motreff P, Lemesle G, Dillinger JG, Lhermusier T, Silvain J, Roule V, Labeque JN, Range G, Ducrocq G, Cottin Y, Blanchard D, Charles Nelson A, De Bruyne B, Chatellier G, Danchin N, Investigators F-MS. Multivessel PCI guided by FFR or angiography for myocardial infarction. N Engl J Med. 2021;385:297–308.

    Article  PubMed  Google Scholar 

  54. Sels JW, Tonino PA, Siebert U, Fearon WF, Van’t Veer M, De Bruyne B, Pijls NH. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (fractional flow reserve versus angiography for multivessel evaluation) study. JACC Cardiovasc Interv. 2011;4:1183–9.

    Article  PubMed  Google Scholar 

  55. Nam J, Briggs A, Layland J, Oldroyd KG, Curzen N, Sood A, Balachandran K, Das R, Junejo S, Eteiba H, Petrie MC, Lindsay M, Watkins S, Corbett S, O’Rourke B, O’Donnell A, Stewart A, Hannah A, McConnachie A, Henderson R, Berry C. Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods. Cost Eff Resour Alloc. 2015;13:19.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Toth GG, De Bruyne B, Rusinaru D, Di Gioia G, Bartunek J, Pellicano M, Vanderheyden M, Adjedj J, Wijns W, Pijls NH, Barbato E. Impact of right atrial pressure on fractional flow reserve measurements: comparison of fractional flow reserve and myocardial fractional flow reserve in 1600 coronary stenoses. JACC Cardiovasc Interv. 2016;9:453–9.

    Article  PubMed  Google Scholar 

  57. Verdier-Watts F, Rioufol G, Mewton N, Sanchez I, Green L, Bonnefoy-Cudraz E, Finet G. Influence of arterial hypotension on fractional flow reserve measurements. EuroIntervention. 2015;11:416–20.

    Article  PubMed  Google Scholar 

  58. Matsumoto H, Nakatsuma K, Shimada T, Ushimaru S, Mikuri M, Yamazaki T, Matsuda T. Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement. J Invasive Cardiol. 2014;26:580–5.

    PubMed  Google Scholar 

  59. Aminian A, Dolatabadi D, Lefebvre P, Khalil G, Zimmerman R, Michalakis G, Lalmand J. Importance of guiding catheter disengagement during measurement of fractional flow reserve in patients with an isolated proximal left anterior descending artery stenosis. Catheter Cardiovasc Interv. 2015;85:595–601.

    Article  PubMed  Google Scholar 

  60. Pijls NH, Bruyne BD. Fractional flow reserve, coronary pressure wires, and drift. Circ J. 2016;80:1704–6.

    Article  PubMed  Google Scholar 

  61. Wakasa N, Kuramochi T, Mihashi N, Terada N, Kanaji Y, Murai T, Lee T, Yonetsu T, Kobashi K, Miyamoto K, Tobata H, Kakuta T. Impact of pressure signal drift on fractional flow reserve-based decision-making for patients with intermediate coronary artery stenosis. Circ J. 2016;80:1812–9.

    Article  PubMed  Google Scholar 

  62. Johnson NP, Toth GG, Lai D, Zhu H, Acar G, Agostoni P, Appelman Y, Arslan F, Barbato E, Chen SL, Di Serafino L, Dominguez-Franco AJ, Dupouy P, Esen AM, Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jimenez-Navarro MF, Katritsis DG, Kocaman SA, Koo BK, Lopez-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, Oud N, Puymirat E, Rieber J, Rioufol G, Rodes-Cabau J, Sedlis SP, Takeishi Y, Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne B, Gould KL. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol. 2014;64:1641–54.

    Article  PubMed  Google Scholar 

  63. Ahn JM, Park DW, Shin ES, Koo BK, Nam CW, Doh JH, Kim JH, Chae IH, Yoon JH, Her SH, Seung KB, Chung WY, Yoo SY, Lee JB, Choi SW, Park K, Hong TJ, Lee SY, Han M, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park SJ, Investigatorsdagger I-F. Fractional flow reserve and cardiac events in coronary artery disease: data from a prospective IRIS-FFR registry (interventional cardiology research incooperation society fractional flow reserve). Circulation. 2017;135:2241–51.

    Article  PubMed  Google Scholar 

  64. Lam MK, Sen H, Tandjung K, Lowik MM, Basalus MW, Mewes JC, Stoel MG, van Houwelingen KG, Linssen GC, Ijzerman MJ, Doggen CJ, von Birgelen C. Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial. Catheter Cardiovasc Interv. 2015;85:524–31.

    Article  PubMed  Google Scholar 

  65. Kikuta Y, Cook CM, Sharp ASP, Salinas P, Kawase Y, Shiono Y, Giavarini A, Nakayama M, De Rosa S, Sen S, Nijjer SS, Al-Lamee R, Petraco R, Malik IS, Mikhail GW, Kaprielian RR, Wijntjens GWM, Mori S, Hagikura A, Mates M, Mizuno A, Hellig F, Lee K, Janssens L, Horie K, Mohdnazri S, Herrera R, Krackhardt F, Yamawaki M, Davies J, Takebayashi H, Keeble T, Haruta S, Ribichini F, Indolfi C, Mayet J, Francis DP, Piek JJ, Di Mario C, Escaned J, Matsuo H, Davies JE. Pre-Angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: primary results of the international multicenter iFR GRADIENT registry. JACC Cardiovasc Interv. 2018;11:757–67.

    Article  PubMed  Google Scholar 

  66. Kawase Y, Kawasaki M, Kikuchi J, Hirata T, Okamoto S, Tanigaki T, Omori H, Ota H, Okubo M, Kamiya H, Hirakawa A, Matsuo H. Residual pressure gradient across the implanted stent: an important factor of post-PCI physiological results. J Cardiol. 2017;71:458–63.

    Article  PubMed  Google Scholar 

  67. Omori H, Kawase Y, Mizukami T, Tanigaki T, Hirata T, Kikuchi J, Ota H, Sobue Y, Miyake T, Kawamura I, Okubo M, Kamiya H, Hirakawa A, Kawasaki M, Nakagawa M, Tsuchiya K, Suzuki Y, Ito T, Terashima M, Kondo T, Suzuki T, Escaned J, Matsuo H. Comparisons of nonhyperemic pressure ratios: predicting functional results of coronary revascularization using longitudinal vessel interrogation. JACC Cardiovasc Interv. 2020;13:2688–98.

    Article  PubMed  Google Scholar 

  68. Balla C, Pavasini R, Ferrari R. Treatment of angina: where are we? Cardiology. 2018;140:52–67.

    Article  CAS  PubMed  Google Scholar 

  69. Yamashita J, Tanaka N, Shindo N, Ogawa M, Kimura Y, Sakoda K, Murata N, Hokama Y, Hoshino K, Ikeda S, Yamashina A. Seven-year clinical outcomes of patients with moderate coronary artery stenosis after deferral of revascularization based on gray-zone fractional flow reserve. Cardiovasc Interv Ther. 2015;30:209–15.

    Article  PubMed  Google Scholar 

  70. Ishii M, Kuramitsu S, Yamanaga K, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Kanemura N, Sonoda S, Yokoi H, Tanaka N, Tsujita K, J- CONFIRM Registry Investigators. Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization. Eur Heart J Cardiovasc Pharmacother. 2022. https://doi.org/10.1093/ehjcvp/pvac008.

    Article  PubMed  Google Scholar 

  71. Davies JE, Whinnett ZI, Francis DP, Manisty CH, Aguado-Sierra J, Willson K, Foale RA, Malik IS, Hughes AD, Parker KH, Mayet J. Evidence of a dominant backward-propagating “suction” wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation. 2006;113:1768–78.

    Article  PubMed  Google Scholar 

  72. Siebes M, Kolyva C, Verhoeff BJ, Piek JJ, Spaan JA. Potential and limitations of wave intensity analysis in coronary arteries. Med Biol Eng Comput. 2009;47:233–9.

    Article  PubMed  Google Scholar 

  73. Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESCSD. ESC/EACTS guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2018;2019(55):4–90.

    Google Scholar 

  74. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, Tarkin J, Petraco R, Broyd C, Jabbour R, Sethi A, Baker CS, Bellamy M, Al-Bustami M, Hackett D, Khan M, Lefroy D, Parker KH, Hughes AD, Francis DP, Di Mario C, Mayet J, Davies JE. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (adenosine vasodilator independent stenosis evaluation) study. J Am Coll Cardiol. 2012;59:1392–402.

    Article  CAS  PubMed  Google Scholar 

  75. Escaned J, Echavarria-Pinto M, Garcia-Garcia HM, van de Hoef TP, de Vries T, Kaul P, Raveendran G, Altman JD, Kurz HI, Brechtken J, Tulli M, Von Birgelen C, Schneider JE, Khashaba AA, Jeremias A, Baucum J, Moreno R, Meuwissen M, Mishkel G, van Geuns RJ, Levite H, Lopez-Palop R, Mayhew M, Serruys PW, Samady H, Piek JJ, Lerman A, Group AIS. Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: results of ADVISE II international, multicenter study (adenosine vasodilator independent stenosis evaluation II). JACC Cardiovasc Interv. 2015;8:824–33.

    Article  PubMed  Google Scholar 

  76. Petraco R, Al-Lamee R, Gotberg M, Sharp A, Hellig F, Nijjer SS, Echavarria-Pinto M, van de Hoef TP, Sen S, Tanaka N, Van Belle E, Bojara W, Sakoda K, Mates M, Indolfi C, De Rosa S, Vrints CJ, Haine S, Yokoi H, Ribichini FL, Meuwissen M, Matsuo H, Janssens L, Katsumi U, Di Mario C, Escaned J, Piek J, Davies JE. Real-time use of instantaneous wave-free ratio: results of the ADVISE in-practice: an international, multicenter evaluation of instantaneous wave-free ratio in clinical practice. Am Heart J. 2014;168:739–48.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Cook CM, Jeremias A, Petraco R, Sen S, Nijjer S, Shun-Shin MJ, Ahmad Y, de Waard G, van de Hoef T, Echavarria-Pinto M, van Lavieren M, Al Lamee R, Kikuta Y, Shiono Y, Buch A, Meuwissen M, Danad I, Knaapen P, Maehara A, Koo BK, Mintz GS, Escaned J, Stone GW, Francis DP, Mayet J, Piek JJ, van Royen N, Davies JE. Fractional flow reserve/instantaneous wave-free ratio discordance in angiographically intermediate coronary stenoses: an analysis using doppler-derived coronary flow measurements. JACC Cardiovasc Interv. 2017;10:2514–24.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Akasaka T, Yamamuro A, Kamiyama N, Koyama Y, Akiyama M, Watanabe N, Neishi Y, Takagi T, Shalman E, Barak C, Yoshida K. Assessment of coronary flow reserve by coronary pressure measurement: comparison with flow- or velocity-derived coronary flow reserve. J Am Coll Cardiol. 2003;41:1554–60.

    Article  PubMed  Google Scholar 

  79. Lee JM, Shin ES, Nam CW, Doh JH, Hwang D, Park J, Kim KJ, Zhang J, Koo BK. Discrepancy between fractional flow reserve and instantaneous wave-free ratio: clinical and angiographic characteristics. Int J Cardiol. 2017;245:63–8.

    Article  PubMed  Google Scholar 

  80. Lee JM, Shin ES, Nam CW, Doh JH, Hwang D, Park J, Kim KJ, Zhang J, Ahn C, Koo BK. Clinical outcomes according to fractional flow reserve or instantaneous wave-free ratio in deferred lesions. JACC Cardiovasc Interv. 2017;10:2502–10.

    Article  PubMed  Google Scholar 

  81. Patel HR, Shah P, Bajaj S, Virk H, Bikkina M, Shamoon F. Intracoronary adenosine-induced ventricular arrhythmias during fractional flow reserve (FFR) measurement: case series and literature review. Cardiovasc Interv Ther. 2017;32:374–80.

    Article  PubMed  Google Scholar 

  82. Berntorp K, Persson J, Koul SM, Patel MR, Christiansen EH, Gudmundsdottir I, Yndigegn T, Omerovic E, Erlinge D, Frobert O, Gotberg M. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: a cost-minimization analysis. Int J Cardiol. 2021;344:54–9.

    Article  PubMed  Google Scholar 

  83. Escaned J, Ryan N, Mejia-Renteria H, Cook CM, Dehbi HM, Alegria-Barrero E, Alghamdi A, Al-Lamee R, Altman J, Ambrosia A, Baptista SB, Bertilsson M, Bhindi R, Birgander M, Bojara W, Brugaletta S, Buller C, Calais F, Silva PC, Carlsson J, Christiansen EH, Danielewicz M, Di Mario C, Doh JH, Erglis A, Erlinge D, Gerber RT, Going O, Gudmundsdottir I, Harle T, Hauer D, Hellig F, Indolfi C, Jakobsen L, Janssens L, Jensen J, Jeremias A, Karegren A, Karlsson AC, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Koo BK, Koul S, Laine M, Lehman SJ, Lindroos P, Malik IS, Maeng M, Matsuo H, Meuwissen M, Nam CW, Niccoli G, Nijjer SS, Olsson H, Olsson SE, Omerovic E, Panayi G, Petraco R, Piek JJ, Ribichini F, Samady H, Samuels B, Sandhall L, Sapontis J, Sen S, Seto AH, Sezer M, Sharp ASP, Shin ES, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Varenhorst C, Vinhas H, Vrints CJ, Walters D, Yokoi H, Frobert O, Patel MR, Serruys P, Davies JE, Gotberg M. Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional flow reserve measurements in stable coronary artery disease and acute coronary syndromes. JACC Cardiovasc Interv. 2018;11:1437–49.

    Article  PubMed  Google Scholar 

  84. Cerrato E, Mejia-Renteria H, Dehbi HM, Ahn JM, Cook C, Dupouy P, Baptista SB, Raposo L, Van Belle E, Gotberg M, Davies JE, Park SJ, Escaned J. Revascularization deferral of nonculprit stenoses on the basis of fractional flow reserve: 1-year outcomes of 8579 patients. JACC Cardiovasc Interv. 2020;13:1894–903.

    Article  PubMed  Google Scholar 

  85. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551–5.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Wald DS, Hadyanto S, Bestwick JP. Should fractional flow reserve follow angiographic visual inspection to guide preventive PCI in STEMI? Eur Heart J Qual Care Clin Outcomes. 2020;6:186–92.

    Article  PubMed  Google Scholar 

  87. Elbadawi A, Dang AT, Hamed M, Eid M, Prakash Hiriyur Prakash M, Saleh M, Gad M, Mamas MA, Rahman F, Elgendy IY. FFR-versus angiography-guided revascularization for nonculprit stenosis in STEMI and multivessel disease. JACC: Cardiovasc Interv. 2022;15:656–66.

    Google Scholar 

  88. Akasaka T, Shiono Y. Nonculprit lesion PCI in STEMI; how to decide and when to perform? JACC: Cardiovasc Interv. 2022;15:667–9.

    Google Scholar 

  89. de Waard GA, Hollander MR, Teunissen PF, Jansen MF, Eerenberg ES, Beek AM, Marques KM, van de Ven PM, Garrelds IM, Danser AH, Duncker DJ, van Royen N. Changes in coronary blood flow after acute myocardial infarction: insights from a patient study and an experimental porcine model. JACC Cardiovasc Interv. 2016;9:602–13.

    Article  PubMed  Google Scholar 

  90. Lee SH, Kim HK, Lee JM, Hong YJ, Lim KS, Kim HB, Choi KH, Shin ES, Nam CW, Doh JH, Yang JH, Song YB, Hahn JY, Choi SH, Jeong MH, Samady H, Escaned J. Coronary circulatory indexes in non-infarct-related vascular territories in a porcine acute myocardial infarction model. JACC Cardiovasc Interv. 2020;13:1155–67.

    Article  PubMed  Google Scholar 

  91. Sen S, Ahmad Y, Dehbi HM, Howard JP, Iglesias JF, Al-Lamee R, Petraco R, Nijjer S, Bhindi R, Lehman S, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Harle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Silva PC, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J, Davies JE. Clinical events after deferral of lad revascularization following physiological coronary assessment. J Am Coll Cardiol. 2019;73:444–53.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87–94.

    Article  CAS  PubMed  Google Scholar 

  93. Nijjer SS, Sen S, Petraco R, Mayet J, Francis DP, Davies JE. The instantaneous wave-free ratio (iFR) pullback: a novel innovation using baseline physiology to optimise coronary angioplasty in tandem lesions. Cardiovasc Revasc Med. 2015;16:167–71.

    Article  PubMed  Google Scholar 

  94. De Bruyne B, Pijls NH, Heyndrickx GR, Hodeige D, Kirkeeide R, Gould KL. Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation. Circulation. 2000;101:1840–7.

    Article  PubMed  Google Scholar 

  95. Warisawa T, Cook CM, Howard JP, Ahmad Y, Doi S, Nakayama M, Goto S, Yakuta Y, Karube K, Shun-Shin MJ, Petraco R, Sen S, Nijjer S, Al Lamee R, Ishibashi Y, Matsuda H, Escaned J, di Mario C, Francis DP, Akashi YJ, Davies JE. Physiological pattern of disease assessed by pressure-wire pullback has an influence on fractional flow reserve/instantaneous wave-free ratio discordance. Circ Cardiovasc Interv. 2019;12: e007494.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Warisawa T, Cook CM, Seligman H, Howard JP, Ahmad Y, Rajkumar C, Doi S, Nakayama M, Tanigaki T, Omori H, Nakajima A, Yamanaka F, Goto S, Yakuta Y, Karube K, Uetani T, Kikuta Y, Shiono Y, Kawase Y, Nishina H, Nakamura S, Escaned J, Akashi YJ, Matsuo H, Davies JE. Per-vessel level analysis of fractional flow reserve and instantaneous wave-free ratio discordance-insights from the AJIP registry. Circ J. 2020;84:1034–8.

    Article  PubMed  Google Scholar 

  97. Van’t Veer M, Pijls NHJ, Hennigan B, Watkins S, Ali ZA, De Bruyne B, Zimmermann FM, van Nunen LX, Barbato E, Berry C, Oldroyd KG. Comparison of different diastolic resting indexes to iFR: are they all equal? J Am Coll Cardiol. 2017;70:3088–96.

    Article  PubMed  Google Scholar 

  98. Svanerud J, Ahn JM, Jeremias A, van 't Veer M, Gore A, Maehara A, Crowley A, Pijls NHJ, De Bruyne B, Johnson NP, Hennigan B, Watkins S, Berry C, Oldroyd KG, Park SJ, Ali ZA. Validation of a novel non-hyperaemic indexof coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. Euro Intervention. 2018;14:806–14.

    PubMed  Google Scholar 

  99. Lee JM, Lee SH, Hwang D, Rhee TM, Choi KH, Kim J, Park J, Kim HY, Jung HW, Cho YK, Yoon HJ, Song YB, Hahn JY, Nam CW, Shin ES, Doh JH, Hur SH, Koo BK. Long-term clinical outcomes of nonhyperemic pressure ratios: resting full-cycle ratio, diastolic pressure ratio, and instantaneous wave-free ratio. J Am Heart Assoc. 2020;9: e016818.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Kawase Y, Omori H, Kawasaki M, Tanigaki T, Hirata T, Okamoto S, Ota H, Kikuchi J, Okubo M, Kamiya H, Hirakawa A, Suzuki T, Matsuo H. Postocclusional hyperemia for fractional flow reserve after percutaneous coronary intervention. Circ Cardiovasc Interv. 2017;10:e005674. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005674.

    Article  PubMed  Google Scholar 

  101. Morioka Y, Arashi H, Otsuki H, Yamaguchi J, Hagiwara N. Relationship between instantaneous wave-free ratio and fractional flow reserve in patients receiving hemodialysis. Cardiovasc Interv Ther. 2018;33:256–63.

    Article  PubMed  Google Scholar 

  102. Kojima S, Ishikawa S, Ohsawa K, Mori H. Determination of effective and safe dose for intracoronary administration of nicorandil in dogs. Cardiovasc Res. 1990;24:727–32.

    Article  CAS  PubMed  Google Scholar 

  103. Miyazaki T, Moritani K, Miyoshi S, Asanagi M, Zhao LS, Mitamura H, Ogawa S. Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia. J Cardiovasc Pharm. 1995;26:949–56.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshiaki Kawase.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawase, Y., Matsuo, H., Kuramitsu, S. et al. Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention and therapeutics—update 2022. Cardiovasc Interv and Ther 37, 425–439 (2022). https://doi.org/10.1007/s12928-022-00863-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-022-00863-1

Keywords

Navigation